What general conclusions can we draw from kinase profiling data sets?

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 7, 2013, Pages 1425-1433

  Sutherland, Jeffrey J ^a   Gao, Cen ^a   Cahya, Suntara ^a   Vieth, Michal ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Data concordance; Inhibitor promiscuity; Kinase profiling; Kinase space; Selectivity; Type I type II inhibitor

Indexed keywords

LAPATINIB; NILOTINIB; PHOSPHOTRANSFERASE INHIBITOR;

ARTICLE; BIOCHEMISTRY; CONCENTRATION RESPONSE; CRYSTAL STRUCTURE; DOSE RESPONSE; ENZYME ACTIVITY; LIGAND BINDING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ACTIVITY RELATION;

EID: 84878884695     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2012.12.023     Document Type: Review

References (29)

1. A. Hopkins Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 4 2008 682 690
2. Z.A. Knight, H. Lin, and K.M. Shokat Targeting the cancer kinome through polypharmacology Nat. Rev. Cancer 10 2010 130 137
3. D.G.-E. Fabbro, and Carlos Garcia Targeting protein kinases in cancer therapy Curr. Opin. Drug Discov. Dev. 5 2002 701 712
4. S.K. Grant Therapeutic protein kinase inhibitors Cell. Mol. Life Sci. 66 2009 1163 1177
5. D.C. Swinney, and J. Anthony How were new medicines discovered? Nat. Rev. Drug Discov. 10 2011 507 519
6. L.N. Kwong, J.C. Costello, H. Liu, S. Jiang, T.L. Helms, A.E. Langsdorf, D. Jakubosky, G. Genovese, F.L. Muller, J.H. Jeong, R.P. Bender, G.C. Chu, K.T. Flaherty, J.A. Wargo, J.J. Collins, and L. Chin Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma Nat. Med. 2012
7. T.R. Wilson, J. Fridlyand, Y. Yan, E. Penuel, L. Burton, E. Chan, J. Peng, E. Lin, Y. Wang, J. Sosman, A. Ribas, J. Li, J. Moffat, D.P. Sutherlin, H. Koeppen, M. Merchant, R. Neve, and J. Settleman Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature 487 2012 505 509
8. B. Apsel, J.A. Blair, B. Gonzalez, T.M. Nazif, M.E. Feldman, B. Aizenstein, R. Hoffman, R.L. Williams, K.M. Shokat, and Z.A. Knight Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases Nat. Chem. Biol. 4 2008 691 699
9. M. Garnett, E. Edelman, S. Heidorn, C. Greenman, A. Dastur, K. Lau, P. Greninger, I. Thompson, X. Luo, J. Soares, Q. Liu, F. Iorio, D. Surdez, L. Chen, R. Milano, G. Bignell, A. Tam, H. Davies, J. Stevenson, S. Barthorpe, S. Lutz, F. Kogera, K. Lawrence, A. McLaren-Douglas, X. Mitropoulos, T. Mironenko, H. Thi, L. Richardson, W. Zhou, F. Jewitt, T. Zhang, P. O'Brien, J. Boisvert, S. Price, W. Hur, W. Yang, X. Deng, A. Butler, H. Choi, J. Chang, J. Baselga, I. Stamenkovic, J. Engelman, S. Sharma, O. Delattre, J. Saez-Rodriguez, N. Gray, J. Settleman, P. Futreal, D. Haber, M. Stratton, S. Ramaswamy, U. McDermott, and C. Benes Systematic identification of genomic markers of drug sensitivity in cancer cells Nature 483 2012 570 575
10. E. Lounkine, M.J. Keiser, S. Whitebread, D. Mikhailov, J. Hamon, J.L. Jenkins, P. Lavan, E. Weber, A.K. Doak, S. Cote, B.K. Shoichet, and L. Urban Large-scale prediction and testing of drug activity on side-effect targets Nature 486 2012 361 367
11. J. Scheiber, B. Chen, M. Milik, S.C. Sukuru, A. Bender, D. Mikhailov, S. Whitebread, J. Hamon, K. Azzaoui, L. Urban, M. Glick, J.W. Davies, and J.L. Jenkins Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis J. Chem. Inf. Model. 49 2009 308 317
12. A.F. Fliri, W.T. Loging, P.F. Thadeio, and R.A. Volkmann Analysis of drug-induced effect patterns to link structure and side effects of medicines Nat. Chem. Biol. 1 2005 389 397
13. F. Brianso, M.C. Carrascosa, T.I. Oprea, and J. Mestres Cross-pharmacology analysis of G protein-coupled receptors Curr. Top. Med. Chem. 11 2011 1956 1963
14. B. Chen, Y. Ding, and D.J. Wild Improving integrative searching of systems chemical biology data using semantic annotation J. Cheminform 4 2012 6 17
15. G.V. Paolini, R.H. Shapland, W.P. van Hoorn, J.S. Mason, and A.L. Hopkins Global mapping of pharmacological space Nat. Biotechnol. 24 2006 805 815 (Pubitemid 44086621)
16. P. Bamborough, D. Drewry, G. Harper, G.K. Smith, and K. Schneider Assessment of chemical coverage of kinome space and its implications for kinase drug discovery J. Med. Chem. 51 2008 7898 7914
17. J.T. Metz, E.F. Johnson, N.B. Soni, P.J. Merta, L. Kifle, and P.J. Hajduk Navigating the kinome Nat. Chem. Biol. 7 2011 200 202
18. M. Vieth, R.E. Higgs, D.H. Robertson, M. Shapiro, E.A. Gragg, and H. Hemmerle Kinomics - structural biology and chemogenomics of kinase inhibitors and targets Biochim. Biophys. Acta 1697 2004 243 257 (Pubitemid 38326776)
19. M. Vieth, J.J. Sutherland, D.H. Robertson, and R.M. Campbell Kinomics: characterizing the therapeutically validated kinase space Drug Discov Today 10 2005 839 846 (Pubitemid 40824738)
20. M.I. Davis, J.P. Hunt, S. Herrgard, P. Ciceri, L.M. Wodicka, G. Pallares, M. Hocker, D.K. Treiber, and P.P. Zarrinkar Comprehensive analysis of kinase inhibitor selectivity Nat. Biotechnol. 29 2011 1046 1051
21. T. Anastassiadis, S.W. Deacon, K. Devarajan, H. Ma, and J.R. Peterson Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity Nat. Biotechnol. 29 2011 1039 1045
22. J. Mestres, E. Gregori-Puigjane, S. Valverde, and R.V. Sole Data completeness - the Achilles heel of drug-target networks Nat. Biotechnol. 26 2008 983 984
23. A. Edwards, R. Isserlin, G. Bader, S. Frye, T. Willson, and F. Yu Too many roads not taken Nature 470 2011 163 165
24. P.P. Graczyk Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases J. Med. Chem. 50 2007 5773 5779 (Pubitemid 350106032)
25. A.C. Cheng, J. Eksterowicz, S. Geuns-Meyer, and Y. Sun Analysis of kinase inhibitor selectivity using a thermodynamics-based partition index J. Med. Chem. 53 2010 4502 4510
26. P. Brandt, A.J. Jensen, and J. Nilsson Small kinase assay panels can provide a measure of selectivity Bioorg Med Chem Lett 19 2009 5861 5863
27. J.T. Metz, and P.J. Hajduk Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks Curr. Opin. Chem. Biol. 14 2010 498 504
28. G. Manning, D. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934 (Pubitemid 35425239)
29. M. Cline, M. Smoot, E. Cerami, A. Kuchinsky, N. Landys, C. Workman, R. Christmas, I. Avila-Campilo, M. Creech, B. Gross, K. Hanspers, R. Isserlin, R. Kelley, S. Killcoyne, S. Lotia, S. Maere, J. Morris, K. Ono, V. Pavlovic, A. Pico, A. Vailaya, P. Wang, A. Adler, B. Conklin, L. Hood, M. Kuiper, C. Sander, I. Schmulevich, B. Schwikowski, G. Warner, T. Ideker, and G. Bader Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2 2007 2366 2382